INS and pancreatic insulinoma: The sparing effect on insulinemia of ABA at a dose of 0.5–1 μg/Kg was unexpected, since micromolar ABA had been reported to stimulate insulin release from human β-pancreatic cells and from rat insulinoma cells in vitro [12].